Novo Nordisk’s Wegovy subsidy application for children and teens rejected again
Earlier this year, Danish Novo Nordisk was denied a subsidy for its obesity drug Wegovy. Now the application for children and young people has also been denied, the pharmaceutical giant says.
Sweden